Leverage Shares’ Post

🔍 Wait untill Elizabeth Warren hears about this! There's a buzz around a potential merger between Humana and Cigna. This move, if it happens, could reshape the landscape of healthcare insurance. 🤝 A little flashback: We've seen similar attempts in the past, like the Aetna-Humana merger talks. That deal, poised to be a game-changer, was ultimately halted by regulators. The main concern? It could have reduced competition in the Medicare Advantage market, potentially impacting consumer choice and pricing. 🚦 The regulatory stop on Aetna-Humana was a significant moment, emphasizing the delicate balance between business growth and market fairness. 💡 As we look at the potential Humana-Cigna merger, it's a blend of excitement and caution. While this merger could bring about innovations, expanded services, and potentially more efficiencies, it's crucial to consider the regulatory perspective. Will this merger pass the competitive fairness test? 📈 The healthcare industry is rapidly evolving, and such mergers are pivotal. But, they must align with broader goals - enhancing consumer choice, ensuring fair pricing, and fostering innovation. 🤔 What are your thoughts? Could this merger be different from Aetna-Humana, and what impacts might it have on the industry? #HealthcareIndustry #HumanaCignaMerger #MarketCompetition #RegulatoryChallenges #InnovationInHealthcare

Market Shake-Up: Cigna and Humana Stock Plunge Amid Merger Talks Cigna and Humana Stock Drops after Reports that the two Healthcare Behemoths are in Discussions to Merge Read More: https://bit.ly/413AD4H #HealthcareMerger #CignaHumanaDeal #StockMarket #InvestingNews #marketvolatility

Private equity continues to outperform every other asset class in the past year as well as over the past 15 years. Healthcare private equity is the best performing private equity sector. contact us to discuss your healthcare exit or partnership with private equity. #privateequity #healthcareprivateequity #outperform #IRR #MOIC

The number of M&A deals in North America in 2023 dropped 32%, but their value rose 368%, driven by four multibillion-dollar transactions. Get the full details on the largest deals and key players in the region in Milliman's 2024 report on global life and health insurance mergers and acquisitions: https://bit.ly/3UyJbO2 #Milliman #RiskManagement #HeathInsurance #LifeInsurance

The latest M&A insights by #PharmaDeals reveals that companies are willing to commit to large sums of cash to acquire established, de-risked assets, leading to higher deal values compared to Q1 2023. Dive into the details in our article https://bit.ly/3XBW9xy #MandA #Dealmaking #BusinessGrowth

Interesting article since the soon to be CEO has more experience with healthcare mergers and acquisitions.

The healthcare giant’s sales of private-equity fund stakes follow years of piling on and driving its holdings to almost $57 billion -- to become one of the largest private markets investors by 2022 The not-for-profit insurer and healthcare provider has been working with Jefferies Financial Group in recent months to sell up to $3.5b of private fund stakes to secondary buyers. A follow up deal of similar size collection is expected later this year. The $3.5b deal comes on the back of a $1.5b exit transaction by Kaiser in 2022 and at least $5b in private markets asset sales it made last year to buyers including Ardian, Blackstone and Apollo. Last year's exits closed at at 10% to 15% discount to the holding value of the assets involved. By end of 2022, Kaiser's investments brought its level of commitments to illiquid assets to nearly 57% of its investible pool, blowing past its own private investment target of 38% of the assets. The average institutional investor holds about 23% of its investments in alternative assets, according to a 2023 Fidelity Investments study.

Hospitals buying independent practices, insurance carriers buying pharmacy benefit managers, insurance carriers buying insurance carriers, mega brokers gobbling up smaller ones... What does this mean for your employer healthcare? When big healthcare companies buy up the smaller ones, there are fewer players in the game. This means less competition, leading to higher costs. So, let's unpack how this big merge-up makes things pricier and cuts our options in half and explore how we can push for changes to make sure there's a healthy fight for you and you're company's dollar. Tackle it here: https://bit.ly/48VGFGI #ethosbenefits #mergers #acquisitions #employeebenefits #healthcare #healthinsurance

Our Partner, Delano Melo Furtado will be speaking at a panel discussion on “Private Equity and M&A Perspectives on the Mittelstand – Opportunities and Challenges” during the Mergermarket Private Equity and M&A Forum Germany.    The panel will discuss evolving dealmaking trends, familial structures, transactional risk insurance, and collaborative opportunities in sectors like tech and healthcare. #india #trilegal #mergermarket #mergersandacquisition #privateequity #technology #healthcare #deals